Bio Loomics, Inc. announced it raised $600,000 in an initial filing from an offering of $600,000

Company

Location

About

BioLoomics, Inc. is a synthetic biology company building the next generation of high-throughput drug screening tools. Our single cell testing technology enables rapid discovery of fluorescent biosensors for new and old drug targets. With biosensor cell lines, drug targets can be measured at specific locations inside living cells, providing valuable kinetic and specificity insights without compromising the speed and scale demands of high-throughput drug discovery.